bupropion has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Excerpt | Relevance | Reference |
---|---|---|
"Improvement of fatigue in patients with multiple sclerosis (MS) who were given bupropion has been previously reported, but scales for lethargy and depression were not used." | 7.76 | Open, uncontrolled, nonrandomized, 9-month, off-label use of bupropion to treat fatigue in a single patient with multiple sclerosis. ( De Sarro, G; Gallelli, L; Loiacono, D; Siniscalchi, A; Tolotta, GA, 2010) |
"Improvement of fatigue in patients with multiple sclerosis (MS) who were given bupropion has been previously reported, but scales for lethargy and depression were not used." | 3.76 | Open, uncontrolled, nonrandomized, 9-month, off-label use of bupropion to treat fatigue in a single patient with multiple sclerosis. ( De Sarro, G; Gallelli, L; Loiacono, D; Siniscalchi, A; Tolotta, GA, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Siniscalchi, A | 1 |
Gallelli, L | 1 |
Tolotta, GA | 1 |
Loiacono, D | 1 |
De Sarro, G | 1 |
1 other study available for bupropion and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
Open, uncontrolled, nonrandomized, 9-month, off-label use of bupropion to treat fatigue in a single patient with multiple sclerosis.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Fatigue; Female; Humans; Middle Aged; Multiple | 2010 |